Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1977 Aug;30(8):738–744. doi: 10.1136/jcp.30.8.738

Aminoglycoside cross-resistance patterns of gentamicin-resistant bacteria.

E T Houang, D Greenwood
PMCID: PMC476537  PMID: 413843

Abstract

Ten strains each of Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa were habituated to gentamicin by serial passage in antibiotic containing medium. Complete cross-resistance to streptomycin, neomycin, kanamycin, and tobramycin in a linear proportional fashion was demonstrated at all stages of habituation. Most strains of Staph. aureus and Ps. aeruginosa showed a greater increase in resistance to gentamicin than to the other three aminoglycosides. E. coli required more transfers to reach the same degree of resistance than did the other two species. Reversion to greater susceptibility to gentamicin took place after serial passage on antibiotic-free media. 'Wild' gentamicin-resistant strains showed no such proportionality of resistance to kanamycin, neomycin, or streptomycin. But many of these strains showed a proportional increase in resistance to tobramycin.

Full text

PDF
738

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barber M., Waterworth P. M. Activity of gentamicin against Pseudomonas and hospital Staphylococci. Br Med J. 1966 Jan 22;1(5481):203–205. doi: 10.1136/bmj.1.5481.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Benveniste R., Davies J. Mechanisms of antibiotic resistance in bacteria. Annu Rev Biochem. 1973;42:471–506. doi: 10.1146/annurev.bi.42.070173.002351. [DOI] [PubMed] [Google Scholar]
  3. Crowe C. C., Sanders E. Is there complete cross-resistance of gram-negative bacilli to gentamicin and tobramycin? Antimicrob Agents Chemother. 1972 Nov;2(5):415–416. doi: 10.1128/aac.2.5.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Datta N. Infection caused by Proteus mirabilis strains with transferrable gentamicin-resistance factors. Lancet. 1975 Jun 21;1(7921):1355–1357. doi: 10.1016/s0140-6736(75)92262-x. [DOI] [PubMed] [Google Scholar]
  5. Davies J. Bacterial resistance to aminoglycoside antibiotics. J Infect Dis. 1971 Dec;124 (Suppl):S7–10. doi: 10.1093/infdis/124.supplement_1.s7. [DOI] [PubMed] [Google Scholar]
  6. Eykyn S., Phillips I. Letter: Gentamicin-resistant Pseudomonas aeruginosa. Lancet. 1975 Apr 12;1(7911):861–862. doi: 10.1016/s0140-6736(75)93042-1. [DOI] [PubMed] [Google Scholar]
  7. Greene W. H., Moody M., Schimpff S., Young V. M., Wiernik P. H. Pseudomonas aeruginosa resistant to carbenicillin and gentamicin. Epidemiologic and clinical aspects in a cancer center. Ann Intern Med. 1973 Nov;79(5):684–689. doi: 10.7326/0003-4819-79-5-684. [DOI] [PubMed] [Google Scholar]
  8. Greenwood D., O'Grady F. Comparison of the responses of Escherichia coli and proteus mirabilis to seven beta-lactam antibodies. J Infect Dis. 1973 Aug;128(2):211–222. doi: 10.1093/infdis/128.2.211. [DOI] [PubMed] [Google Scholar]
  9. Greenwood D. Response profiles: A method of evaluating the activity of beta-lactam antibiotics against Enterobacteria. Chemotherapy. 1977;23(1):11–18. doi: 10.1159/000221965. [DOI] [PubMed] [Google Scholar]
  10. Jacoby G. A. Properties of an R plasmid in Pseudomonas aeruginosa producing amikacin (BB-K8), butirosin, kanamycin, tobramycin, and sisomicin resistance. Antimicrob Agents Chemother. 1974 Dec;6(6):807–810. doi: 10.1128/aac.6.6.807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. KUNIN C. M., WILCOX C., NAJARIAN A., FINLAND M. Susceptibility and crossresistance of bacteria to four related antibiotics: kanamycin, paromomycin, neomycin and streptomycin. Proc Soc Exp Biol Med. 1958 Nov;99(2):312–316. doi: 10.3181/00379727-99-24334. [DOI] [PubMed] [Google Scholar]
  12. Klastersky J., Daneau D., de Maertelaer V. Comparative study of tobramycin and gentamicin with special reference to anti-pseudomonas activity. Clin Pharmacol Ther. 1973 Jan-Feb;14(1):104–111. doi: 10.1002/cpt1973141104. [DOI] [PubMed] [Google Scholar]
  13. Mackintosh I. P., O'Grady F., Greenwood D., Watson B. W., Crichton T. C., Piper R., Ferrer A. A twelve channel bacterial growth monitoring system. Biomed Eng. 1973 Dec;8(12):514–passim. [PubMed] [Google Scholar]
  14. Molavi A., Barza M., Cole W., Berman H., Weinstein L. In vitro assessment of tobramycin, a new aminoglycoside with anti-Pseudomonas activity. Chemotherapy. 1973;18(1):7–16. doi: 10.1159/000221242. [DOI] [PubMed] [Google Scholar]
  15. Pechey D. T., James A. M. Surface lipid of cells of Pseudomonas aeruginosa and its relation to gentamicin-resistance. Biomedicine. 1973 Apr 10;19(4):127–129. [PubMed] [Google Scholar]
  16. Richmond A. S., Simberkoff M. S., Rahal J. J., Jr, Schaefler S. R factors in gentamicin-resistant organisms causing hospital infection. Lancet. 1975 Dec 13;2(7946):1176–1178. doi: 10.1016/s0140-6736(75)92660-4. [DOI] [PubMed] [Google Scholar]
  17. Seal D. V., Strangeways J. E. Letter: Resistant pseudomonads in a neurosurgical unit. Lancet. 1975 Jan 4;1(7897):48–49. doi: 10.1016/s0140-6736(75)92420-4. [DOI] [PubMed] [Google Scholar]
  18. Snelling C. F., Ronald A. R., Cates C. Y., Forsythe W. C. Resistance of gram-negative bacilli to gentamicin. J Infect Dis. 1971 Dec;124 (Suppl):S264–S270. doi: 10.1093/infdis/124.supplement_1.s264. [DOI] [PubMed] [Google Scholar]
  19. Waterworth P. M. The in-vitro activity of tobramycin compared with that of other aminoglycosides. J Clin Pathol. 1972 Nov;25(11):979–983. doi: 10.1136/jcp.25.11.979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Weinstein M. J., Drube C. G., Moss E. L., Jr, Waitz J. A. Microbiologic studies related to bacterial resistance to gentamicin. J Infect Dis. 1971 Dec;124 (Suppl):S11–S17. doi: 10.1093/infdis/124.supplement_1.s11. [DOI] [PubMed] [Google Scholar]
  21. Wretland B., Nord C. E., Wadström T. In vitro sensitivity of isolates of Pseudomonas aeruginosa to carbenicillin, gentamicin, tobramycin, and some other antibiotics. Scand J Infect Dis. 1974;6(1):49–52. doi: 10.3109/inf.1974.6.issue-1.09. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES